AstraZeneca reported 28.94B in Loan Capital for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Alcon AG ALC:SW 4.3B 8M
Amgen AMGN:US $ 33291M 4833M
AstraZeneca AZN:LN 28939M 4338M
AstraZeneca AZN:SS 28.94B 4.34B
Astrazeneca AZN:US 28.94B 4.34B
Bayer BAYN:GR € 36974M 310M
Biogen BIIB:US $ 6272.3M 996.9M
Bristol Myers Squibb BMY:US $ 39677M 2826M
Eli Lilly And LLY:US $ 15522.4M 785.8M
Fresenius FRE:GR € 22142M 127M
Fresenius Medical Care FME:GR € 10570M 100.97M
Galapagos GLPG:NA 19.13M 2.3M
Genmab GEN:DC 374M 10M
GlaxoSmithKline GSK:LN 20736M 294M
GRIFOLS GRF:SM € 6978M 247.04M
H. Lundbeck A/S LUN:DC 5.5B 212M
Hikma Pharmaceutical HIK:LN 751M 13M
Lonza Group LONN:SW 2.79B 5M
Merck MRK:GR € 8195M 526M
Novartis NOVN:VX SF 24715M 1776M
Orion ORNBV:FH 104.7M 200K
Philips PHIA:NA € 6623M 741M
Recordati REC:IM 824.7M 70.95M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M